Life Science Investing FDA Approves Guardant360® CDx as Companion Diagnostic for Eli Lilly and Company's Inluriyo for Treatment of ESR1-mutated Advanced Breast Cancer
Life Science Investing Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership
Life Science Investing Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership
Life Science Investing Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States
Life Science Investing Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test
